News on immunohistochemistry and other tissue-based testing methods.
Proscia said that its partnership with Johns Hopkins, which aims to accelerate research breakthroughs and improve patient outcomes, is one among a number of its recent pathology-related engagements.
Inspirata said that the partners will combine their digital pathology products to address challenges with traditional pathology testing for H. Pylori.
The companies will develop an integrated clinical pathology solution with plans to submit a 510(k) application to the US Food and Drug Administration.
The IMCB-A!maginostic Joint Lab of Excellence will provide AI- and machine learning-based solutions to support computational digital and multiplex pathology.
The extended deal covers multiple blood cancer and solid tumor indications and will leverage several HalioDx technologies and approaches.
